Molecular epidemiology of BCL2 and BCL6 mutations in lymphomas associated with pesticide exposures

被引：0
|
作者：
Greiner, T
Zahm, S
Migliazza, A
Weisenburger, D
机构：
[1] Univ Nebraska, Med Ctr, Omaha, NE USA
[2] NCI, Bethesda, MD 20892 USA
[3] Columbia Univ, New York, NY USA
来源：
LABORATORY INVESTIGATION | 1999年 / 79卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
802
引用
收藏
页码：137A / 137A
页数：1
相关论文
共 50 条
  • [21] Mediastinal B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements
    Ocal, Jon L.
    Feldman, Andrew L.
    Greipp, Patricia T.
    Rimsza, Lisa M.
    JOURNAL OF HEMATOPATHOLOGY, 2022, 15 (03) : 151 - 155
  • [22] Mediastinal B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements
    Jon L. Ocal
    Andrew L. Feldman
    Patricia T. Greipp
    Lisa M. Rimsza
    Journal of Hematopathology, 2022, 15 : 151 - 155
  • [23] BCL2 Negative Follicular Lymphoma with BCL6 Gene Rearrangement Show Mutations of STAT6 DNA Binding Domain
    Ochmann, Marlene
    Copie-Bergman, Christiane
    Baia, Maryse
    Ruminy, Philippe
    Bastard, Christian
    Haioun, Corinne
    Gaulard, Philippe
    Jardin, Fabrice
    Leroy, Karen
    BLOOD, 2012, 120 (21)
  • [24] What does MYC, BCL2, and BCL6 genes 'rearranged' mean in large cell/diffuse B-cell lymphomas?
    Trombetta, Domenico
    Zanelli, Magda
    Garuti, Anna
    Carosi, Illuminato
    Mastracci, Luca
    Ascani, Stefano
    Graziano, Paolo
    Parente, Paola
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 240
  • [25] Triple-Hit B-Cell Lymphomas With MYC, BCL2 and BCL6 Translocations: Morphological, Immunophenotypical, and Clinical Features
    Wang, Wei
    Hu, Shimin
    Lu, Xinyan
    Young, Ken
    Medeiros, Jeffrey
    LABORATORY INVESTIGATION, 2015, 95 : 384A - 384A
  • [26] The role of BCL6 in lymphomas and routes to therapy
    Wagner, Simon D.
    Ahearne, Matthew
    Ferrigno, Paul Ko
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (01) : 3 - 12
  • [27] Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
    Hanno M. Witte
    Jörg Riedl
    Axel Künstner
    Anke Fähnrich
    Julius Ketzer
    Stephanie M. J. Fliedner
    Niklas Reimer
    Veronica Bernard
    Nikolas von Bubnoff
    Hartmut Merz
    Hauke Busch
    Alfred Feller
    Niklas Gebauer
    Targeted Oncology, 2023, 18 : 749 - 765
  • [28] Triple-Hit B-Cell Lymphomas With MYC, BCL2 and BCL6 Translocations: Morphological, Immunophenotypical, and Clinical Features
    Wang, Wei
    Hu, Shimin
    Lu, Xinyan
    Young, Ken
    Medeiros, Jeffrey
    MODERN PATHOLOGY, 2015, 28 : 384A - 384A
  • [29] Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
    Witte, Hanno M. M.
    Riedl, Joerg
    Kuenstner, Axel
    Faehnrich, Anke
    Ketzer, Julius
    Fliedner, Stephanie M. J.
    Reimer, Niklas
    Bernard, Veronica
    von Bubnoff, Nikolas
    Merz, Hartmut
    Busch, Hauke
    Feller, Alfred
    Gebauer, Niklas
    TARGETED ONCOLOGY, 2023, 18 (05) : 749 - 765
  • [30] Molecular features of a new human lymphoma cell line carrying both BCL2 and BCL6 gene rearrangements
    Yonetani, N
    Akasaka, T
    Akasaka, H
    Ohno, H
    Okuma, M
    Miura, I
    Takahashi, N
    Miyanishi, S
    Okumura, A
    Muramatsu, M
    Fukuhara, S
    ONCOGENE, 1998, 17 (08) : 971 - 979
12345